China Cuts Taxes to Boost Generic Drug Industry
China’s government has announced policies to encourage the manufacturing of generic drugs that will include a reduction in corporate income tax of 40% for some producers and faster evaluation of new medicines.
The strategy (link in Chinese) is aimed at cutting health care costs, meeting public demand and building a “healthy China,” the State Council said in an announcement on the government’s website on Tuesday.
- 1China Mulls Ban on Transporting Coal, Ore, Steel by Truck
- 2Update: China Abruptly Ends Anti-Dumping Probe Against U.S. Sorghum
- 3Quick Take: Nigeria Awards $6.7 Billion Rail Project To China
- 4Carrefour Opens New Tech-Infused Grocery Store in Shanghai
- 5U.S., China Strike Trade Deal, Ending Threat of Protective Tariffs
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas